178 related articles for article (PubMed ID: 10413424)
1. Effect of antioxidants on androgen-induced AP-1 and NF-kappaB DNA-binding activity in prostate carcinoma cells.
Ripple MO; Henry WF; Schwarze SR; Wilding G; Weindruch R
J Natl Cancer Inst; 1999 Jul; 91(14):1227-32. PubMed ID: 10413424
[TBL] [Abstract][Full Text] [Related]
2. Prooxidant-antioxidant shift induced by androgen treatment of human prostate carcinoma cells.
Ripple MO; Henry WF; Rago RP; Wilding G
J Natl Cancer Inst; 1997 Jan; 89(1):40-8. PubMed ID: 8978405
[TBL] [Abstract][Full Text] [Related]
3. Androgen and taxol cause cell type-specific alterations of centrosome and DNA organization in androgen-responsive LNCaP and androgen-independent DU145 prostate cancer cells.
Schatten H; Ripple M; Balczon R; Weindruch R; Chakrabarti A; Taylor M; Hueser CN
J Cell Biochem; 2000 Jan; 76(3):463-77. PubMed ID: 10649443
[TBL] [Abstract][Full Text] [Related]
4. Androgen blocks apoptosis of hormone-dependent prostate cancer cells.
Kimura K; Markowski M; Bowen C; Gelmann EP
Cancer Res; 2001 Jul; 61(14):5611-8. PubMed ID: 11454715
[TBL] [Abstract][Full Text] [Related]
5. Androgens inhibit the proliferation of a variant of the human prostate cancer cell line LNCaP.
Joly-Pharaboz MO; Soave MC; Nicolas B; Mebarki F; Renaud M; Foury O; Morel Y; Andre JG
J Steroid Biochem Mol Biol; 1995 Oct; 55(1):67-76. PubMed ID: 7577722
[TBL] [Abstract][Full Text] [Related]
6. NF-kappaB2 processing and p52 nuclear accumulation after androgenic stimulation of LNCaP prostate cancer cells.
Lessard L; Saad F; Le Page C; Diallo JS; Péant B; Delvoye N; Mes-Masson AM
Cell Signal; 2007 May; 19(5):1093-100. PubMed ID: 17292587
[TBL] [Abstract][Full Text] [Related]
7. Androgen-induced oxidative stress in human LNCaP prostate cancer cells is associated with multiple mitochondrial modifications.
Ripple MO; Hagopian K; Oberley TD; Schatten H; Weindruch R
Antioxid Redox Signal; 1999; 1(1):71-81. PubMed ID: 11225734
[TBL] [Abstract][Full Text] [Related]
8. Inter-related in vitro effects of androgens, fatty acids and oxidative stress in prostate cancer: a mechanistic model supporting prevention strategies.
Lin H; Lu JP; Laflamme P; Qiao S; Shayegan B; Bryskin I; Monardo L; Wilson BC; Singh G; Pinthus JH
Int J Oncol; 2010 Oct; 37(4):761-6. PubMed ID: 20811696
[TBL] [Abstract][Full Text] [Related]
9. Regulation of expression of Na+,K+-ATPase in androgen-dependent and androgen-independent prostate cancer.
Blok LJ; Chang GT; Steenbeek-Slotboom M; van Weerden WM; Swarts HG; De Pont JJ; van Steenbrugge GJ; Brinkmann AO
Br J Cancer; 1999 Sep; 81(1):28-36. PubMed ID: 10487609
[TBL] [Abstract][Full Text] [Related]
10. Androgens regulate TRAIL-induced cell death in prostate cancer cells via multiple mechanisms.
Wang D; Lu J; Tindall DJ
Cancer Lett; 2013 Jul; 335(1):136-44. PubMed ID: 23402817
[TBL] [Abstract][Full Text] [Related]
11. Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines.
Mukhopadhyay A; Bueso-Ramos C; Chatterjee D; Pantazis P; Aggarwal BB
Oncogene; 2001 Nov; 20(52):7597-609. PubMed ID: 11753638
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of growth and induction of apoptosis by androgens of a variant of LNCaP cell line.
Joly-Pharaboz MO; Ruffion A; Roch A; Michel-Calemard L; André J; Chantepie J; Nicolas B; Panaye G
J Steroid Biochem Mol Biol; 2000; 73(5):237-49. PubMed ID: 11070352
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
Zaia A; Fraizer GC; Piantanelli L; Saunders GF
Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
[TBL] [Abstract][Full Text] [Related]
14. Androgens stimulate fatty acid synthase in the human prostate cancer cell line LNCaP.
Swinnen JV; Esquenet M; Goossens K; Heyns W; Verhoeven G
Cancer Res; 1997 Mar; 57(6):1086-90. PubMed ID: 9067276
[TBL] [Abstract][Full Text] [Related]
15. Rapid androgen actions on calcium signaling in rat sertoli cells and two human prostatic cell lines: similar biphasic responses between 1 picomolar and 100 nanomolar concentrations.
Lyng FM; Jones GR; Rommerts FF
Biol Reprod; 2000 Sep; 63(3):736-47. PubMed ID: 10952915
[TBL] [Abstract][Full Text] [Related]
16. Induction of AP-1 activity by androgen activation of the androgen receptor in LNCaP human prostate carcinoma cells.
Church DR; Lee E; Thompson TA; Basu HS; Ripple MO; Ariazi EA; Wilding G
Prostate; 2005 May; 63(2):155-68. PubMed ID: 15486991
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of EGR-1 modulates the activity of NF-κB and AP-1 in prostate carcinoma PC-3 and LNCaP cell lines.
Parra E; Ferreira J; Ortega A
Int J Oncol; 2011 Aug; 39(2):345-52. PubMed ID: 21617851
[TBL] [Abstract][Full Text] [Related]
18. Androgens markedly stimulate the accumulation of neutral lipids in the human prostatic adenocarcinoma cell line LNCaP.
Swinnen JV; Van Veldhoven PP; Esquenet M; Heyns W; Verhoeven G
Endocrinology; 1996 Oct; 137(10):4468-74. PubMed ID: 8828509
[TBL] [Abstract][Full Text] [Related]
19. Anti-tumor activity of curcumin against androgen-independent prostate cancer cells via inhibition of NF-κB and AP-1 pathway in vitro.
Liu S; Wang Z; Hu Z; Zeng X; Li Y; Su Y; Zhang C; Ye Z
J Huazhong Univ Sci Technolog Med Sci; 2011 Aug; 31(4):530. PubMed ID: 21823017
[TBL] [Abstract][Full Text] [Related]
20. Androgens induce expression of SPAK, a STE20/SPS1-related kinase, in LNCaP human prostate cancer cells.
Qi H; Labrie Y; Grenier J; Fournier A; Fillion C; Labrie C
Mol Cell Endocrinol; 2001 Sep; 182(2):181-92. PubMed ID: 11514053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
